Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Beevers

Showing results (311-320 of 387) with videos related to

Pageof 39
Sort By:
Acta Ophthalmologica Scandinavica|November 24, 1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?P L Lip, A F Jones, N Price, et al.
Journal of Human Hypertension|March 16, 2012
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complicationsV J Karthikeyan, D A Lane, D G Beevers, et al.
British Medical Journal|February 12, 1977
Angiotensin II in essential hypertensionD G Beevers, J J Morton, C S Nelson, et al.
Journal of Human Hypertension|May 19, 2006
Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?R L Antikainen, T Grodzicki, A J Palmer, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Relation between prognosis and the blood pressure before and during treatment of hypertensive patientsD G Beevers, J Johnston, B L Devine, et al.
International Journal of Cardiology|October 31, 2000
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapyF L Li-Saw-Hee, E Edmunds, A D Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2001
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke ProjectG Y Lip, A D Blann, I S Farooqi, et al.
Journal of Human Hypertension|August 30, 2008
Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjectsR L Antikainen, T Grodzicki, D G Beevers, et al.
Journal of Human Hypertension|May 24, 2000
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP)M Stahl, C J Bulpitt, A J Palmer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes TrialD C Felmeden, A D Blann, C G C Spencer, et al.
Pageof 39

Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
Acta Ophthalmologica Scandinavica|November 24, 1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?P L Lip, A F Jones, N Price, et al.
Journal of Human Hypertension|March 16, 2012
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complicationsV J Karthikeyan, D A Lane, D G Beevers, et al.
British Medical Journal|February 12, 1977
Angiotensin II in essential hypertensionD G Beevers, J J Morton, C S Nelson, et al.
Journal of Human Hypertension|May 19, 2006
Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?R L Antikainen, T Grodzicki, A J Palmer, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Relation between prognosis and the blood pressure before and during treatment of hypertensive patientsD G Beevers, J Johnston, B L Devine, et al.
International Journal of Cardiology|October 31, 2000
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapyF L Li-Saw-Hee, E Edmunds, A D Blann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 19, 2001
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke ProjectG Y Lip, A D Blann, I S Farooqi, et al.
Journal of Human Hypertension|August 30, 2008
Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjectsR L Antikainen, T Grodzicki, D G Beevers, et al.
Journal of Human Hypertension|May 24, 2000
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP)M Stahl, C J Bulpitt, A J Palmer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 10, 2003
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes TrialD C Felmeden, A D Blann, C G C Spencer, et al.
Pageof 39